Galang AI and Theiagen Genomics Announce Official AI Enablement Partnership

Galang AI and Theiagen Genomics announced today an official partnership focused on AI enablement and strategy, bringing Galang AI’s practical approach to responsible AI adoption together with one of the most respected teams working in pathogen genomics and public health bioinformatics.

Theiagen is helping define the future of genomic public health. Its scientists and leaders bring decades of experience across government, academia, and industry, and the company supports public health laboratories in the United States and around the world as they adopt next-generation sequencing, cloud computing, and advanced bioinformatics.

The company’s vision is a world where genomic insights accelerate global progress. Its mission, to harness the full potential of genomics, comes to life through the development of rigorous bioinformatics workflows, deep scientific research, training, and expert support that make sophisticated genomic capabilities more accessible to the people and institutions protecting public health.

“Theiagen is doing the kind of work that changes what is possible for public health. Their team pairs deep scientific expertise with a real willingness to rethink how research, data, and technology come together. We are proud to support that vision and help turn AI’s potential into practical, responsible capability.”

James Galang, co-founder of Galang AI

That work is especially important as next-generation sequencing transforms how scientists understand infectious disease, food safety, molecular diagnostics, and environmental threats. Theiagen’s team has built a reputation for pairing scientific depth with implementation: not only advancing methods, but helping laboratories put modern genomic tools to work in real-world settings.

Theiagen also brings an AI-forward mindset to that mission. Its culture of research, technical rigor, and continuous innovation creates a strong foundation for exploring how AI can support scientific organizations without compromising quality, trust, or expert judgment.

Through the partnership, Galang AI will support Theiagen’s broader AI journey with strategy and enablement designed around the organization’s people, knowledge, and operating environment. The work will remain intentionally practical and responsible, with an emphasis on useful systems, trusted information, clear human review, and adoption that strengthens rather than distracts from the scientific mission.

The partnership reflects what both organizations believe about transformative technology: its value is realized when deep expertise and modern tools reinforce one another. Theiagen brings world-class pathogen genomics and bioinformatics leadership. Galang AI brings the ability to translate rapidly evolving AI capabilities into governed, usable systems. Together, the organizations are creating a foundation for thoughtful innovation at the intersection of AI, genomics, and public health.

Specific initiatives will remain appropriately private as the work develops, but the shared direction is clear. Theiagen will continue pushing the boundaries of what is possible with genomic data and next-generation sequencing, while Galang AI helps ensure that AI becomes a practical extension of the company’s research, expertise, and forward-looking culture.

Learn more about Theiagen Genomics and its work to transform pathogen surveillance and genomic epidemiology at https://www.theiagen.com/.